Gui Long Pharmaceutical

Guilong Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the development, manufacture, and marketing of Traditional Chinese Medicine (TCM) and over-the-counter (OTC) healthcare products. The company is widely recognized for its strong portfolio in respiratory health, featuring flagship brands such as Guilong Ganlu for cough relief and Man Yan Ning for the treatment of chronic pharyngitis. Founded in 1989, Guilong established itself as a leader in the Chinese consumer health market before being acquired by the British multinational Reckitt in 2013. Today, it operates as a key subsidiary within Reckitt's health division, leveraging its heritage in TCM to serve the growing demand for cough and throat care in the Asia-Pacific region.